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TO THE EDITOR
Dorfman–Chanarin syndrome (DCS) is
an autosomal recessive, neutral lipid
storage disorder with ichthyosis
(NLSDI) due to loss-of-function muta-
tions in CGI-58 (a/b-hydrolase domain-
containing protein 5, ABHD5). CGI-58
encodes a 39 kDa protein, a widely
expressed cofactor in mammalian
tissues including epidermis that acti-
vates adipose triglyceride (TG) lipase
(reviewed in Schweiger et al., 2009;
Yamaguchi and Osumi, 2009), as well
as other still unidentified TG lipases
(Radner et al., 2009). CGI-58 expres-
sion increases during keratinocyte
differentiation; and conversely, knock-
down of this cofactor reduces keratino-
cyte differentiation (Akiyama et al.,
2008). Epidermal permeability barrier
defects due in part to lamellar/nonla-
mellar phase separation of secreted
lipids, within extracellular domains of
the stratum corneum (SC) have been
proposed to account for the barrier
abnormalities in NLSDI (Elias and
Williams, 1985; Demerjian et al.,
2006). Although defective extracellular
lipid organization clearly is one con-
tributor (Demerjian et al., 2006), we
assessed whether diversion of free fatty
acid (FA) into esterified lipids causes
lipid abnormalities that further impact
barrier formation.
We recently reported a DCS patient
with a, to our knowledge, previously
unreported CGI-58 missense mutation
(Ujihara et al., 2010), exhibiting abnor-
mal barrier-related structures resem-
bling other NLSDI patients (Demerjian
et al., 2006). Both mild and severely
affected ichthyotic SCs revealed in-
creased TG and decreased FA levels in
comparison with SC fraction from
normal subjects (Ujihara et al., 2010).
Pertinently, the extent of the increase in
TG levels correlated with site-specific
differences in the severity of the derma-
tosis (Ujihara et al., 2010). These
observations suggest that divergence
of FA to TG contributes to disease
phenotype in NLSDI.
We previously showed that o-O-
acylceramides (or acylCer) that have
only been identified in differentiated
layers of epidermis in terrestrial mam-
mals are essential constituents of the
epidermal permeability barrier; that is,
lack of acylCer formation results in
neonatal death due to abnormal
epidermal permeability barrier function
(Vasireddy et al., 2007). AcylCer and
the de-o-O-esterified form (o-hydroxy
[o-OH] ceramide [Cer]) are present
either as free (unbound) or bound
species (Uchida and Holleran, 2008).
The latter form a continuous lipid
monolayer, the corneocyte-bound lipid
envelope (CLE); that is, a pool of o-OH
Cer, which is covalently bound to the
external surface of the cornified envel-
ope (Uchida and Holleran, 2008).
Although free acylCer are critical for
the formation of the lamellar mem-
branes (Bouwstra et al., 1998), our
previous studies suggest the CLE is also
important for normal permeability
barrier function (Behne et al., 2000).
Prior studies suggest that FAs der-
ived from TG are used in the
o-O-esterification step to form acylCer
(Wertz and Downing, 1990). Moreover,
TG, linoleate, and acylCer, but not
phosphoglycerolipid content, decline
in acyl-CoA: diacylglycerol acyltrans-
ferase-2-deficient mice, which also
show a permeability barrier abnormal-
ity (Stone et al., 2004). In addition,
linoleate, which is the predominant FA
that is used for o-O-esterification, is
enriched in TG in mouse skin (Stone
et al., 2004). Thus, we hypothesized
that a failure of TG hydrolysis, due to
abnormal CGI-58 function, could at-
tenuate permeability barrier formation
in NLSDI by decreasing acylCer con-
tent of affected SC.
Therefore, we first investigated the
lipid profiles in solvent extracts of SC
from this DCS patient (Ujihara et al.,
2010). Neither cholesterol (Ujihara
et al., 2010) nor total (bulk) Cer
(Figure 1a) content was altered. Yet,
Cer comprises a family of at least
10 species in humans (Uchida and
Holleran, 2008). Because not only bulk
Cer amount but also each individual
Cer species contributes to the formation
of competent lamellar structures re-
quired for barrier function (Bouwstra
et al., 1998), we subfractionated Cer
into individual Cer species. Whereas
the major Cer subfractions, NS (Cer 2),
NP (Cer 3), and AS (Cer 5) were not
significantly altered, acylCer were
present at only trace levels in the
patient sample (Figure 1b; because
sample amounts were limited, other
minor Cer species; that is, EOH (Cer 4),
AP (Cer 6) (AP), AH (Cer 7) could not be
quantitated) (abbreviations for Cer
structures are according to Motta.
et al. and Robson K. et al., details
reviewed in Uchida and Holleran,
2008).
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Not only bound o-OH Cer, but also
bound o-OH FA (resulting from the
subsequent hydrolysis of some bound
o-OH Cer by ceramidase) decline
significantly in DCS (Figure 1c). As with
TG accumulation (Ujihara et al., 2010),
the decrease in these bound lipids
reflects disease severity. Accordingly,
this patient, as well as in two additional
DCS patients (Demerjian et al., 2006),
lacked CLE on ultrastructural analysis of
affected SC (Figure 2).
Finally, we investigated whether
the decreased acylCer in DCS is
due to a gain-of-function of mutation
in CGI-58, rather than a deficiency of
TG-derived FA. A substantial decrease
in acylglucosylCer (¼ acylCer precur-
sor), but not in other glucosylCer
species, was evident in lentivirus-ex-
pressed CGI-58 shRNA-treated cultured
human keratinocytes (Figure 1d).
Hence, by facilitating the lipolysis of
TG, CGI-58 provides FA for o-O-
esterification leading to acylCer forma-
tion. The recent demonstration of a
lethal, postnatal permeability barrier
defect and deficiency of both acylCer
and bound o-OH Cer in cgi-58-null
mice (Radner et al., 2009) further
supports this conclusion.
We conclude from these and pre-
vious studies that CGI-58 not only
facilitates TG lipolysis but also provides
FA for the o-O-esterification of Cer
leading to acylCer production, as
well as bound o-OH Cer generation
leading to CLE formation (see Supple-
mentary Figure S1 online). These studies
highlight that the deficiency of an
essential barrier constitute, acylCer, likely
contributes to the permeability barrier
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Figure 1. Lipid profile in the stratum corneum. Both unbound acylCer and bound o-OH Cer deficiencies occur in a Dorfman–Chanarin syndrome (DCS) stratum
corneum (SC) (a–c), whereas diminished CGI-58 expression decreases acylglucosylCer production (d). Normal SC from sunburn lesion as controls. CHK
transfected with lentivirus-expressed shRNA (CGI-58 or control vector) were cultured in differentiation-inducing medium (Uchida et al., 2001). Lipids were
isolated from SC or cells and quantitated using thin-layer chromatography-scanning densitometry as described previously (Uchida et al., 2001). n¼1 (DC) and
n¼ 3 (normal). All studies were approved by the institutional ethics review boards (Kochi University and University of California, San Francisco) and were
performed according to the Declaration of Helsinki Principles.
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Figure 2. Electron micrographs display lack of continuous lipid monolayer, CLE, in the SC from
two DCS patients (Demerjian et al., 2006) vs. normal subject (inset, N). Skin samples were fixed
in Karnovsky’s fixative, and post-fixed with ruthenium tetroxide or osmium tetroxide, as previously
described (Behne et al., 2000). Ultrathin sections were examined, after further contrasted with lead
citrate, with a Zeiss 10A (Carl Zeiss, Thornwood, NY) (Behne et al., 2000). Arrows (with solid line,
presence and with dotted line, absence) indicate CLE structures. Bars¼100 nm.
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abnormality in DCS. Although the
function of the CLE is still unclear, a
role as a necessary scaffold for the
lamellar bilayer organization is likely
(Uchida and Holleran, 2008). Thus, CLE
deficiency, coupled with disorganization
of extracellular lamellar bilayers, likely
merge to provoke the barrier abnor-
mality in NLSDI (see Supplementary
Figure S2 online). Finally, to overcome
this metabolic disadvantage in forming
the epidermal permeability barrier, epi-
dermal proliferation likely increases,
which in turn results in hyperkeratosis,
phenotypic features common to virtually
all of the ichthyoses (Demerjian et al.,
2006; Akiyama et al., 2008), that is, ‘A
compromised permeability barrier ‘drives’
the hyperproliferative epidermis in NLSDI
and other ichthyoses’ (Elias et al., 2008).
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TO THE EDITOR
The risk of developing human papillo-
mavirus (HPV)-related benign and
malignant cutaneous lesions is mark-
edly increased in immunosuppressed
people such as organ-transplant recipi-
ents (Harwood et al., 2000) and HIV-
infected patients (Grulich et al., 2007;
Stier and Baranoski, 2008). Although
HPV DNA in plucked eyebrow hair has
been well investigated (Boxman et al.,
1997) in renal transplant recipients and
immunocompetent patients (ICPs) and
correlated with both benign and malig-
nant cutaneous lesions (Struijk et al.,
2003; Plasmeijer et al., 2009), very little
is known about HPV prevalence in
eyebrow hair from HIV patients.
The study design was approved by
the research ethics committee and allAbbreviations: HPV, human papillomavirus; ICP, immunocompetent patient
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